# Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Lung Non-Small Cell Carcinoma

- Company: National Cancer Institute (NCI)
- Sector: Lung Non-Small Cell Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT06498635

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.